unknown
Stage
1
Investors
About
Impel NeuroPharma develops intranasal drug-delivery technologies designed to transport therapeutics to the central nervous system; its Precision Olfactory Delivery (POD) platform is focused on rapid delivery of treatments for migraine and other CNS disorders.
Explore Impel NeuroPharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.